DARNITSA GROUP Trademark

Trademark Overview


On Monday, October 7, 2019, a trademark application was filed for DARNITSA GROUP with the United States Patent and Trademark Office. The USPTO has given the DARNITSA GROUP trademark a serial number of 79276074. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by PRIVATE JOINT STOCK COMPANY ¿PHARMACEUTICAL FIRM "DARNITSA". The DARNITSA GROUP trademark is filed in the Pharmaceutical Products category with the following description:

Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for human purposes for medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory...
darnitsa group

General Information


Serial Number79276074
Word MarkDARNITSA GROUP
Filing DateMonday, October 7, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6235826
Registration DateTuesday, January 5, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Goods and ServicesAntiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for human purposes for medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Drugs for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal drinks; medicinal oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes for ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; Pre-filled syringes containing pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Air purifying preparations; food for babies; protein dietary supplements; Tissues impregnated with pharmaceutical lotions for treating dermatological conditions; Alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical preparations for medical purposes for the diagnosis of pregnancy; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical or veterinary purposes; surgical glues; surgical dressings; candy, medicated; candy for medical purposes; sanitary preparations for medical purposes; plasters for medical purposes
Disclaimer with Predetermined Text"GROUP"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY ¿PHARMACEUTICAL FIRM "DARNITSA"
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressUA

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY ¿PHARMACEUTICAL FIRM "DARNITSA"
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressUA

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY ¿PHARMACEUTICAL FIRM "DARNITSA"
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressUA

Trademark Events


Event DateEvent Description
Thursday, August 3, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 30, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 9, 2021GENERIC MADRID TRANSACTION SENT TO IB
Friday, April 9, 2021GENERIC MADRID TRANSACTION CREATED
Monday, April 5, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Friday, December 18, 2020NEW REPRESENTATIVE AT IB RECEIVED
Sunday, December 6, 2020NOTIFICATION PROCESSED BY IB
Friday, November 13, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020ASSIGNED TO LIE
Thursday, August 13, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 28, 2020REFUSAL PROCESSED BY IB
Wednesday, February 12, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 12, 2020REFUSAL PROCESSED BY MPU
Saturday, January 18, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 17, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Friday, January 10, 2020ASSIGNED TO EXAMINER
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 9, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB